Stay updated on Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial
Sign up to get notified when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FkBDHdbOLEqQB_tg5TZx7ON8DRDI.uncropped.jpg&w=3840&q=75)
Latest updates to the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe website has been updated to version v2.10.0, adding two more interventions/treatments, two more study numbers, and noting that the study now has 33 locations.SummaryDifference0.3%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7, replacing the previous version v2.9.6.SummaryDifference0.0%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the version of the web page content.SummaryDifference0.0%
- Check30 days agoChange DetectedThe value of Revision has changed from v2.9.3 to v2.9.5, indicating an update or modification to the content of the web page.SummaryDifference0.0%
- Check31 days agoChange DetectedThe value of Revision has changed from v2.9.1 to v2.9.3, indicating an update or modification to the content of the web page.SummaryDifference0.0%
- Check32 days agoChange DetectedThe value 'Show more Show more Revision: v2.9.0' has recently changed to 'Show less'. This change indicates a revision to the study details, possibly reflecting updates or modifications to the clinical trial protocol.SummaryDifference60%
Stay in the know with updates to Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Immune Response to Dolutegravir in Pediatric HIV Clinical Trial page.